You
FT

Filana Therapeutics, Inc.

Company · Health · TX
Statements1
Sightings1
Years covered2026 – now
Primary sourceSEC Form 10-K
All statements
2026 – nowCurrentOur mission is to develop transformative medicines to improve the lives of patients with central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A. Our science is based on modulating the activity of a critical protein in the brain for patients with certain CNS disorders, such as TSC.Mission · Impact · SEC Form 10-K, filed 2026-03-12
Organization
Type
Company
Industry
Health
Location
TX, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗